Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
210.1 USD | -2.04% | -4.13% | -11.18% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.18% | 11.05B | |
+46.37% | 58.71B | |
-3.48% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.92% | 26.55B | |
-22.28% | 18.98B | |
+1.12% | 12.51B | |
+24.80% | 12.08B | |
+21.77% | 11.94B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260